Early research (Phase 1)Looking for participantsNCT07774572What this trial is testingExploration of Circular RNA in B-cell Hematologic MalignanciesWho this might be right forLymphoma, B-Cell Refractory Ruijin Hospital 30
Early research (Phase 1)UnknownNCT05645601What this trial is testingCAR-NK Targeted CD19 for r/r B-cell MalignanciesWho this might be right forAdult Relapsed/Refractory B-cell Hematologic Malignancies Affiliated Hospital to Academy of Military Medical Sciences 12
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Study completedNCT00005592What this trial is testingRadioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Alabama at Birmingham 23
Testing effectiveness (Phase 2)Study completedNCT00119392What this trial is testingYttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+14 more Fred Hutchinson Cancer Center 42
Early research (Phase 1)Study completedNCT00006098What this trial is testingPS-341 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00045292What this trial is testingValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00109993What this trial is testingCampath-1H + FK506 and Methylprednisolone for GVHDWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT00827099What this trial is testingUmbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+2 more Northside Hospital, Inc. 5
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175415What this trial is testingHEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory+2 more Princess Maxima Center for Pediatric Oncology
Testing effectiveness (Phase 2)Active Not RecruitingNCT02981628What this trial is testingInotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRefractory B Acute Lymphoblastic Leukemia+1 more Children's Oncology Group 80
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Not applicableEnded earlyNCT00005786What this trial is testingArsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or LeukemiaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic Leukemia+8 more National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT01534715What this trial is testingIMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaWho this might be right forLymphoma, Non-HodgkinChronic Lymphocytic Leukemia ImmunoGen, Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT03743246What this trial is testingEvaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)Who this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin Celgene 21
Testing effectiveness (Phase 2)Study completedNCT00337168What this trial is testingS0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 36
Testing effectiveness (Phase 2)Looking for participantsNCT06481735What this trial is testingTCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALLWho this might be right forAcute Lymphocytic Leukemia Chinese PLA General Hospital 30